HEALTH: Summary of Nov 10, 2026

By · Published on

Illustration of laboratory glassware
AI-generated illustration; does not depict the actual event.

A US federal study linked two forever chemicals to aggressive breast cancer, and bird flu returned to Norfolk poultry. Swedish researchers tied parents’ autoimmune diseases to type 1 diabetes in children, campaigners in Ireland and Northern Ireland pressed for lung cancer screening, and Cambridge researchers estimated the lives cleaner air could save.

Two common forever chemicals are linked to a higher rate of aggressive breast cancer

Women with higher blood levels of two forever chemicals, PFOA and PFOS, were more likely to develop oestrogen receptor-negative breast cancer, a study by the US National Institutes of Health has found. Published in the Journal of Clinical Oncology, it found that those with the most PFOA had a 67% higher rate of this aggressive form than those with the least, while for PFOS the rate was 93% higher. No clear link was found with breast cancer overall.

The researchers measured 17 different PFAS chemicals in blood samples taken years before diagnosis from participants in the Sister Study, a long-running project with more than 50,000 volunteers in the United States and Puerto Rico. The analysis compared 1,609 women who developed breast cancer with 2,269 who did not. ER-negative tumours, which make up about 15 per cent of breast cancers, do not respond to hormone therapy, so the authors suspect effects on the immune system or gene activity. They called for research on newer replacement chemicals.

PFAS are a large family of synthetic compounds whose chemical stability means they persist in the environment for a very long time, earning them the nickname forever chemicals. The first was made in 1934, and their widespread use began in 1938 with the invention of Teflon. They are found in products from waterproof fabric and food packaging to firefighting foam and cosmetics. PFOS was added to the Stockholm Convention’s list of persistent pollutants in 2009, and PFOA followed in 2019.


Bird flu is confirmed at a poultry site in Norfolk, the county’s first case this autumn

The UK government has confirmed Norfolk’s first case of bird flu this autumn, after the Animal and Plant Health Agency found highly pathogenic avian influenza H5N1 in commercial poultry at premises near Dersingham. A protection zone of 3km and a surveillance zone of 10km have been set up around the site, and all the birds there will be humanely culled. The outbreak brings the number of cases in the UK so far this autumn to five.

Inside the protection zone, the movement of birds and eggs is restricted, as is contact between people and poultry or eggs, and all keepers must follow strict biosecurity rules. The UK Health Security Agency says the risk to the general public remains very low, and the Food Standards Agency says properly cooked poultry and eggs are safe to eat. Birds seldom pass the virus to humans, and it has not spread onwards from person to person. Poultry in England cannot be vaccinated against the disease.

H5N1 is a subtype of the influenza A virus that causes avian influenza and is now established in many bird populations worldwide, spreading quickly through flocks and with migrating wild birds. Its highly pathogenic form was first detected in 1996, among geese on farms in southern China. Between 2003 and December 2025, the World Health Organization recorded 993 confirmed human cases, leading to 477 deaths, and an estimated half billion farmed birds had been slaughtered by December 2024 to contain it.


Parents’ autoimmune diseases are linked to a higher risk of type 1 diabetes in their children

Children whose mothers had an autoimmune disease before or during pregnancy face a higher risk of type 1 diabetes, and the same holds for fathers diagnosed before the birth, a Swedish study has found. Led by Huan Zhang of Karolinska Institutet in Stockholm and published in JAMA Pediatrics, it drew on national registers covering 1,455,645 children born between 2001 and 2014. Over a median follow-up of 15.3 years, 10,273 of them developed the condition.

A maternal autoimmune disease raised the risk by roughly half, with an adjusted hazard ratio of 1.57, and a paternal one by a similar amount, at 1.51. The link was strongest when a parent had type 1 diabetes themselves, with ratios of 4.51 for mothers and 5.79 for fathers. Comparing cousins weakened but did not remove the association. An accompanying editorial argued that children of parents with other endocrine autoimmune diseases should also be screened, though the researchers lacked genetic data.

Type 1 diabetes is an autoimmune disease in which the immune system destroys the cells in the pancreas that make insulin, the hormone the body uses to turn blood sugar into energy. Its cause is not fully understood but is thought to involve a mix of genetic and environmental factors. There is no known way to prevent it, and patients need insulin to survive, either through several injections a day or through a pump that delivers it continuously.


Calls grow for lung cancer screening in Ireland and Northern Ireland

The Irish Cancer Society wants a nationwide programme to check for lung cancer, citing a pilot led by the Beaumont RCSI Cancer Centre. More than 14,000 people, mainly ex-smokers aged 55 to 74, were contacted through their GPs, and more than 2,100 attended scans at mobile units parked at GAA clubs. Almost 40 people without symptoms were found to have early-stage lung cancer, 80% of them at stage 1, and many have already been successfully treated.

The Department of Health in Dublin said experts had recommended referring screening to the health technology regulator for assessment. In Northern Ireland, which had promised a targeted programme by April 2027, officials now say there is no definitive timeline because of funding. Joan McConville, 71, a former teacher from Banbridge whose cancer returned this year, believes screening might have caught it sooner. A consultant estimated it could mean an additional 100 people a year surviving or avoiding the disease.

Lung cancer screening aims to find early tumours before symptoms appear, when they are more likely to be curable, because long-term survival is far higher when the disease is caught at a localised stage than at an advanced one. The main methods are low-dose CT scans, chest X-rays and sputum tests, and expert bodies in the United States and the European Commission’s science advisers endorse low-dose CT for people at high risk. England has begun rolling out screening, with full coverage expected by 2030.


Meeting WHO air quality guidelines could save more than 9 million lives a year, study estimates

Meeting the World Health Organization’s guidelines for fine particulate matter could prevent or postpone an estimated 9.4 million deaths a year across 136 low- and middle-income countries, researchers at the University of Cambridge have found. Cutting nitrogen dioxide to the recommended level could prevent or postpone around 1.1 million more. Even the WHO’s looser interim targets would bring about 6.6 million fewer deaths linked to fine particles, according to the paper in Environment International.

Cleaner air could also mean 7.3 million fewer new cases of coronary heart disease, 2.8 million of chronic obstructive pulmonary disease, 2.3 million of stroke and 1.1 million of dementia each year. Medical savings would include $11.8 billion for heart disease and $8.6 billion for dementia, with further gains in productivity. The average annual PM2.5 level in the countries studied was 30.44 micrograms per cubic metre, more than six times the WHO limit, and the study appeared as leaders met at COP31.

Particulate matter is made up of microscopic solid or liquid particles suspended in the air, and the fine particles known as PM2.5 measure 2.5 micrometres or less across. It is considered the most dangerous form of air pollution because it can penetrate deep into the lungs and reach other organs through the bloodstream, and it is classed as a Group 1 carcinogen. Across the world, PM2.5 played a part in 7.9 million deaths in 2023, and no level of exposure is considered safe.

In this topic